TipHub

₹2,261.7

▲ +77.12 +3.53%

As of 29 Jul 2026 · delayed

NSE Listed · Pharmaceuticals

Glenmark Pharmaceuticals Ltd. (GLENMARK)

Volume: 5,93,720Avg Vol 1W: 5,34,924Avg Vol 1M: 5,64,61852W Range:₹1,792.6₹2,474
NSE BSE www.glenmarkpharma.com AI Report
Key Ratios
Checked just now
Market Cap₹63,825 Cr
Current Price₹2,261.7
Previous Close₹2,184.58
High / Low (52w)₹2,474 / ₹1,792.6
Volume5,93,720
Avg Vol (1W)5,34,924
Avg Vol (1M)5,64,618
Stock P/E211.77
Book Value₹372.51
Dividend Yield0.12%
ROE28.08%
ROA6.84%
Revenue (TTM)—
Revenue Growth12.77%
Profit Margin8.15%
Total Debt₹513 Cr
Shares Outstanding28 Cr
Face Value₹1
EPS (TTM)₹10.68
P/B6.07
Debt / Equity0.06
50 DMA₹2,229.2
200 DMA₹2,096.52
Day change+3.53%
Price Chart
₹2,261.7▲ 4.81% · 1Y
₹2418₹157161.7L
2025-07-29
2026-07-29

20-day avg volume: 5.6L shares

Pros
  • Healthy return on equity of 28.1%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 212.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹3,244 Cr₹3,434 Cr₹3,388 Cr₹3,256 Cr₹3,264 Cr₹6,047 Cr₹3,901 Cr₹3,771 Cr
EBITDA₹502 Cr₹521 Cr₹509 Cr₹448 Cr₹477 Cr₹2,419 Cr₹760 Cr₹804 Cr
Net Profit₹340 Cr₹354 Cr₹348 Cr₹5 Cr₹47 Cr₹610 Cr₹403 Cr₹301 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹2,636 Cr₹2,251 Cr₹2,009 Cr₹13,435 Cr₹2,395 Cr₹1,539 Cr₹2,360 Cr₹2,147 Cr
EBITDA₹807 Cr₹568 Cr₹373 Cr₹1,979 Cr₹740 Cr₹49 Cr₹546 Cr₹279 Cr
Net Profit₹595 Cr₹414 Cr₹148 Cr₹1,047 Cr₹330 Cr₹-739 Cr₹282 Cr₹-74 Cr
EPS———37.11————
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹12,595 Cr₹13,289 Cr₹14,685 Cr₹15,604 Cr₹17,083 Cr₹19,372 Cr₹14,359 Cr₹16,050 Cr
Total Liabilities₹7,432 Cr₹7,684 Cr₹8,615 Cr₹8,539 Cr₹7,645 Cr₹9,532 Cr₹6,511 Cr₹7,200 Cr
Equity₹5,163 Cr₹5,605 Cr₹6,070 Cr₹7,064 Cr₹9,438 Cr₹9,839 Cr₹7,848 Cr₹8,849 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹2,000 Cr₹1,767 Cr₹1,859 Cr₹1,641 Cr₹1,667 Cr₹1,266 Cr₹782 Cr₹-147 Cr
Investing₹-1,013 Cr₹-699 Cr₹-784 Cr₹-675 Cr₹-333 Cr₹-528 Cr₹4,561 Cr₹2 Cr
Financing₹-468 Cr₹-739 Cr₹-445 Cr₹-442 Cr₹-520 Cr₹-77 Cr₹-3,906 Cr₹787 Cr
Free Cash Flow₹2,000 Cr₹1,767 Cr₹1,859 Cr₹1,641 Cr₹1,667 Cr₹1,266 Cr₹782 Cr₹-147 Cr
Shareholding
Promoter 46.65% Institutions 39.5% Public 13.85%
Efficiency & Working Capital
ROCE18.5%
Interest Coverage9.6
Dividend Payout—
Debtor Days92 d
Inventory Days83 d
Payable Days71 d
Cash Conversion Cycle104 d
Working Capital Days175 d
Shareholding Details

As of 2026-06-30

Promoter46.7%
FII20.9%
DII18.6%
Institutions39.5%
Public13.8%
Promoter Pledge0%
No. of Shareholders2,11,418
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters46.6%46.6%46.6%46.6%46.6%46.6%46.6%46.6%46.6%46.7%46.7%46.7%
FIIs24.8%23.7%21.4%21%23.1%23.5%23.2%20.6%20.7%19.2%20.3%20.9%
DIIs10.3%10.9%13.4%13.9%13.2%13.8%14.6%17.6%18.6%20.1%19.3%18.6%
Public18.2%18.7%18.6%18.4%17.1%16%15.6%15.1%14%14.1%13.7%13.8%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,32,6852,09,9311,99,4511,92,6301,93,9491,95,0591,92,7241,90,2101,98,7892,01,5841,96,1052,11,418
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Saldanha Family TrustShareholding of Promoter and Promoter Group45.4%12.82 Cr
Hdfc Mutual Fund - Hdfc Mid-cap FundPublic Shareholding6.2%1.76 Cr
Government Pension Fund GlobalPublic Shareholding3.9%1.10 Cr
Amansa Holdings Private LimitedPublic Shareholding2.2%62,51,753
Invesco India Contra FundPublic Shareholding2.2%62,17,592
Bandhan Nifty 200 Momentum 30 Index FundPublic Shareholding1.3%36,02,621
Uti Multi Cap FundPublic Shareholding1.2%32,58,742
Blanche Elizabeth SaldanhaShareholding of Promoter and Promoter Group0.4%11,14,327
Glenn Mario SaldanhaShareholding of Promoter and Promoter Group0.4%10,11,644
Cherylann Maria PintoShareholding of Promoter and Promoter Group0.3%7,63,915
Robin Joseph PintoShareholding of Promoter and Promoter Group0.2%4,99,500
Neha SaldanhaShareholding of Promoter and Promoter Group0%26,000
Board of Directors
NameDesignationYear
Glenn SaldanhaChairman / Executive Director / M D / Promoter2025
Cheryl PintoED / WTD / Promoter2025
Anurag MantriED / President / Global CFO2025
B E SaldanhaNon Executive Director2025
Sona Saira RamasastryIndependent Non Exe. Director2025
Dipankar BhattacharjeeIndependent Non Exe. Director2025
V R IyerIndependent Non Exe. Director2025
Pradeep Kumar SinhaIndependent Non Exe. Director2025
Harish KuberCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical Products₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹4,485 Cr48.6%
North America₹1,922 Cr20.8%
Europe₹1,195 Cr13%
Rest of the World ( Including Latin₹1,625 Cr17.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹12372828
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-31Board Meetings—
dividend2025-10-03₹2.5 (250%)Interim
dividend2025-09-15₹2.5 (250%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202518,84300401818,901
202511,687000011,687
2025841004018900
Insider / Designated-Person Trades

10 recent disclosure(s)

Mr. Praveen D KurkalDisposal · 500
Mr. Praveen D KurkalDisposal · 1,000
Mr. Praveen D KurkalDisposal · 1,000
ROBIN PINTOAcquisition · 250
SRIDHAR GORTHIDisposal · 559
NEHA SALDANHAAcquisition · 20,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market17/06/2025 · 3,57,499
Company Information
Incorporated1977
ChairmanGlenn Saldanha
AuditorSuresh Surana & Associates LLP
Investor Email[email protected]
🌐 www.glenmarkpharma.com ↗

📍 B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Grover Jewells LimitedGK Energy LimitedGujarat Kidney & Super Speciality Ltd.GKW LimitedGland Pharma LimitedGlaxosmithkline Pharmaceuticals Ltd.Gujarat Lease Financing LimitedGlobal Education LimitedGlobale Tessile LimitedGlobal Pet Industries Ltd.Global Vectra Helicorp Ltd.Globe Enterprises (India) Ltd.All “G” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search